Beth Israel Deaconess Medical Center (Boston). The BIDMC Cancer Center has more than 160 faculty; receives more than $70 million in annual research funds; and offers 20 specialty programs. The hospital is a Blue Distinction Center for Complex & Rare Cancers for eight cancer types and received a “high performing” national ranking for cancer care by U.S. News & World Report for 2016-17. The cancer center recently named a new clinical director, Manuel Hidalgo, MD, PhD, a pancreatic cancer specialist who now oversees BIDMC clinical cancer programs.
 |
 
|
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
